Bristol-Myers Squibb Company PFD CONV 2
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) Stock Competitors & Peer Comparison
See (BMYMP) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.29% |
| RHHBY | $51.99 | +1.74% | 334.9B | 20.31 | $2.56 | +2.98% |
| RHHBF | $425.14 | +0.46% | 330.3B | 20.22 | $20.52 | +2.99% |
| RHHVF | $403.29 | +8.69% | 321B | 19.78 | $20.39 | +3.08% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.41% |
| NVSEF | $142.65 | +0.00% | 272.2B | 20.44 | $6.98 | +3.32% |
| GLAXF | $25.70 | +0.00% | 102.6B | 13.39 | $1.92 | +3.49% |
| SNYNF | $88.76 | +4.06% | 102.4B | 18.35 | $4.65 | +5.67% |
| CHGCY | $25.10 | +0.72% | 82.1B | 29.70 | $0.84 | +3.29% |
| CHGCF | $51.14 | +0.44% | 80.3B | 29.22 | $1.67 | +3.54% |
Stock Comparison
BMYMP vs RHHBY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, RHHBY has a market cap of 334.9B. Regarding current trading prices, BMYMP is priced at $400.00, while RHHBY trades at $51.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas RHHBY's P/E ratio is 20.31. In terms of profitability, BMYMP's ROE is +0.39%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, BMYMP is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check RHHBY's competition here
BMYMP vs RHHBF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, RHHBF has a market cap of 330.3B. Regarding current trading prices, BMYMP is priced at $400.00, while RHHBF trades at $425.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas RHHBF's P/E ratio is 20.22. In terms of profitability, BMYMP's ROE is +0.39%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, BMYMP is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check RHHBF's competition here
BMYMP vs RHHVF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, RHHVF has a market cap of 321B. Regarding current trading prices, BMYMP is priced at $400.00, while RHHVF trades at $403.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas RHHVF's P/E ratio is 19.78. In terms of profitability, BMYMP's ROE is +0.39%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, BMYMP is more volatile compared to RHHVF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check RHHVF's competition here
BMYMP vs AZNCF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, BMYMP is priced at $400.00, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, BMYMP's ROE is +0.39%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, BMYMP is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check AZNCF's competition here
BMYMP vs NVSEF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, NVSEF has a market cap of 272.2B. Regarding current trading prices, BMYMP is priced at $400.00, while NVSEF trades at $142.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas NVSEF's P/E ratio is 20.44. In terms of profitability, BMYMP's ROE is +0.39%, compared to NVSEF's ROE of +0.32%. Regarding short-term risk, BMYMP is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check NVSEF's competition here
BMYMP vs GLAXF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, GLAXF has a market cap of 102.6B. Regarding current trading prices, BMYMP is priced at $400.00, while GLAXF trades at $25.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas GLAXF's P/E ratio is 13.39. In terms of profitability, BMYMP's ROE is +0.39%, compared to GLAXF's ROE of +0.36%. Regarding short-term risk, BMYMP is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check GLAXF's competition here
BMYMP vs SNYNF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, SNYNF has a market cap of 102.4B. Regarding current trading prices, BMYMP is priced at $400.00, while SNYNF trades at $88.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas SNYNF's P/E ratio is 18.35. In terms of profitability, BMYMP's ROE is +0.39%, compared to SNYNF's ROE of +0.14%. Regarding short-term risk, BMYMP is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check SNYNF's competition here
BMYMP vs CHGCY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, CHGCY has a market cap of 82.1B. Regarding current trading prices, BMYMP is priced at $400.00, while CHGCY trades at $25.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas CHGCY's P/E ratio is 29.70. In terms of profitability, BMYMP's ROE is +0.39%, compared to CHGCY's ROE of +0.24%. Regarding short-term risk, BMYMP is more volatile compared to CHGCY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check CHGCY's competition here
BMYMP vs CHGCF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, CHGCF has a market cap of 80.3B. Regarding current trading prices, BMYMP is priced at $400.00, while CHGCF trades at $51.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas CHGCF's P/E ratio is 29.22. In terms of profitability, BMYMP's ROE is +0.39%, compared to CHGCF's ROE of +0.23%. Regarding short-term risk, BMYMP is more volatile compared to CHGCF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check CHGCF's competition here
BMYMP vs BAYRY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, BAYRY has a market cap of 43.7B. Regarding current trading prices, BMYMP is priced at $400.00, while BAYRY trades at $11.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas BAYRY's P/E ratio is -17.37. In terms of profitability, BMYMP's ROE is +0.39%, compared to BAYRY's ROE of -0.07%. Regarding short-term risk, BMYMP is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check BAYRY's competition here
BMYMP vs OTSKY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, OTSKY has a market cap of 36.9B. Regarding current trading prices, BMYMP is priced at $400.00, while OTSKY trades at $36.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas OTSKY's P/E ratio is 16.21. In terms of profitability, BMYMP's ROE is +0.39%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, BMYMP is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check OTSKY's competition here
BMYMP vs OTSKF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, OTSKF has a market cap of 34B. Regarding current trading prices, BMYMP is priced at $400.00, while OTSKF trades at $64.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas OTSKF's P/E ratio is 14.88. In terms of profitability, BMYMP's ROE is +0.39%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, BMYMP is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check OTSKF's competition here
BMYMP vs DSNKY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, DSNKY has a market cap of 30.1B. Regarding current trading prices, BMYMP is priced at $400.00, while DSNKY trades at $16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas DSNKY's P/E ratio is 18.58. In terms of profitability, BMYMP's ROE is +0.39%, compared to DSNKY's ROE of +0.16%. Regarding short-term risk, BMYMP is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check DSNKY's competition here
BMYMP vs DSKYF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, DSKYF has a market cap of 29.1B. Regarding current trading prices, BMYMP is priced at $400.00, while DSKYF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas DSKYF's P/E ratio is 17.98. In terms of profitability, BMYMP's ROE is +0.39%, compared to DSKYF's ROE of +0.16%. Regarding short-term risk, BMYMP is more volatile compared to DSKYF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check DSKYF's competition here
BMYMP vs ALPMY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, ALPMY has a market cap of 26.1B. Regarding current trading prices, BMYMP is priced at $400.00, while ALPMY trades at $14.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas ALPMY's P/E ratio is 14.28. In terms of profitability, BMYMP's ROE is +0.39%, compared to ALPMY's ROE of +0.18%. Regarding short-term risk, BMYMP is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check ALPMY's competition here
BMYMP vs ALPMF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, ALPMF has a market cap of 24B. Regarding current trading prices, BMYMP is priced at $400.00, while ALPMF trades at $14.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas ALPMF's P/E ratio is 13.14. In terms of profitability, BMYMP's ROE is +0.39%, compared to ALPMF's ROE of +0.17%. Regarding short-term risk, BMYMP is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check ALPMF's competition here
BMYMP vs ORINY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, ORINY has a market cap of 21.4B. Regarding current trading prices, BMYMP is priced at $400.00, while ORINY trades at $37.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas ORINY's P/E ratio is 17.43. In terms of profitability, BMYMP's ROE is +0.39%, compared to ORINY's ROE of +0.49%. Regarding short-term risk, BMYMP is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check ORINY's competition here
BMYMP vs GIKLY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, GIKLY has a market cap of 13.9B. Regarding current trading prices, BMYMP is priced at $400.00, while GIKLY trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas GIKLY's P/E ratio is 14.72. In terms of profitability, BMYMP's ROE is +0.39%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, BMYMP is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check GIKLY's competition here
BMYMP vs CHJTF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, CHJTF has a market cap of 12B. Regarding current trading prices, BMYMP is priced at $400.00, while CHJTF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas CHJTF's P/E ratio is 21.00. In terms of profitability, BMYMP's ROE is +0.39%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, BMYMP is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check CHJTF's competition here
BMYMP vs ORINF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, ORINF has a market cap of 11.7B. Regarding current trading prices, BMYMP is priced at $400.00, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas ORINF's P/E ratio is 18.94. In terms of profitability, BMYMP's ROE is +0.39%, compared to ORINF's ROE of +0.49%. Regarding short-term risk, BMYMP is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check ORINF's competition here
BMYMP vs RCDTF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, RCDTF has a market cap of 11.4B. Regarding current trading prices, BMYMP is priced at $400.00, while RCDTF trades at $55.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas RCDTF's P/E ratio is 21.17. In terms of profitability, BMYMP's ROE is +0.39%, compared to RCDTF's ROE of +0.24%. Regarding short-term risk, BMYMP is more volatile compared to RCDTF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check RCDTF's competition here
BMYMP vs CSPCY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, CSPCY has a market cap of 10.9B. Regarding current trading prices, BMYMP is priced at $400.00, while CSPCY trades at $3.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas CSPCY's P/E ratio is 19.00. In terms of profitability, BMYMP's ROE is +0.39%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, BMYMP is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check CSPCY's competition here
BMYMP vs GIFOF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, BMYMP is priced at $400.00, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas GIFOF's P/E ratio is 12.46. In terms of profitability, BMYMP's ROE is +0.39%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, BMYMP is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check GIFOF's competition here
BMYMP vs KYKOF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, KYKOF has a market cap of 7.6B. Regarding current trading prices, BMYMP is priced at $400.00, while KYKOF trades at $14.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas KYKOF's P/E ratio is 17.81. In terms of profitability, BMYMP's ROE is +0.39%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, BMYMP is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check KYKOF's competition here
BMYMP vs GIFLF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, GIFLF has a market cap of 7.2B. Regarding current trading prices, BMYMP is priced at $400.00, while GIFLF trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas GIFLF's P/E ratio is 14.89. In terms of profitability, BMYMP's ROE is +0.39%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, BMYMP is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check GIFLF's competition here
BMYMP vs OPHLY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, OPHLY has a market cap of 7.1B. Regarding current trading prices, BMYMP is priced at $400.00, while OPHLY trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas OPHLY's P/E ratio is 16.26. In terms of profitability, BMYMP's ROE is +0.39%, compared to OPHLY's ROE of +0.09%. Regarding short-term risk, BMYMP is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check OPHLY's competition here
BMYMP vs OPHLF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, BMYMP is priced at $400.00, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas OPHLF's P/E ratio is 15.48. In terms of profitability, BMYMP's ROE is +0.39%, compared to OPHLF's ROE of +0.09%. Regarding short-term risk, BMYMP is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check OPHLF's competition here
BMYMP vs DPHAY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, BMYMP is priced at $400.00, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, BMYMP's ROE is +0.39%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, BMYMP is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check DPHAY's competition here
BMYMP vs SNPHY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, SNPHY has a market cap of 3.9B. Regarding current trading prices, BMYMP is priced at $400.00, while SNPHY trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas SNPHY's P/E ratio is 16.65. In terms of profitability, BMYMP's ROE is +0.39%, compared to SNPHY's ROE of +0.13%. Regarding short-term risk, BMYMP is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check SNPHY's competition here
BMYMP vs SNPHF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, BMYMP is priced at $400.00, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas SNPHF's P/E ratio is 15.26. In terms of profitability, BMYMP's ROE is +0.39%, compared to SNPHF's ROE of +0.17%. Regarding short-term risk, BMYMP is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check SNPHF's competition here
BMYMP vs VRBCF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, VRBCF has a market cap of 3.4B. Regarding current trading prices, BMYMP is priced at $400.00, while VRBCF trades at $408.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas VRBCF's P/E ratio is 19.35. In terms of profitability, BMYMP's ROE is +0.39%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, BMYMP is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check VRBCF's competition here
BMYMP vs HAWPY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, BMYMP is priced at $400.00, while HAWPY trades at $53.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas HAWPY's P/E ratio is 14.38. In terms of profitability, BMYMP's ROE is +0.39%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, BMYMP is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check HAWPY's competition here
BMYMP vs HAWPF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, BMYMP is priced at $400.00, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas HAWPF's P/E ratio is 12.77. In terms of profitability, BMYMP's ROE is +0.39%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, BMYMP is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check HAWPF's competition here
BMYMP vs PTKFF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, PTKFF has a market cap of 2.2B. Regarding current trading prices, BMYMP is priced at $400.00, while PTKFF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas PTKFF's P/E ratio is N/A. In terms of profitability, BMYMP's ROE is +0.39%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, BMYMP is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check PTKFF's competition here
BMYMP vs LYPHF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, LYPHF has a market cap of 1.3B. Regarding current trading prices, BMYMP is priced at $400.00, while LYPHF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas LYPHF's P/E ratio is 16.39. In terms of profitability, BMYMP's ROE is +0.39%, compared to LYPHF's ROE of +0.04%. Regarding short-term risk, BMYMP is more volatile compared to LYPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check LYPHF's competition here
BMYMP vs TGRNF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, TGRNF has a market cap of 633.9M. Regarding current trading prices, BMYMP is priced at $400.00, while TGRNF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas TGRNF's P/E ratio is 9.90. In terms of profitability, BMYMP's ROE is +0.39%, compared to TGRNF's ROE of +0.05%. Regarding short-term risk, BMYMP is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check TGRNF's competition here
BMYMP vs JCRRF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, JCRRF has a market cap of 508.7M. Regarding current trading prices, BMYMP is priced at $400.00, while JCRRF trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas JCRRF's P/E ratio is -34.75. In terms of profitability, BMYMP's ROE is +0.39%, compared to JCRRF's ROE of +0.06%. Regarding short-term risk, BMYMP is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check JCRRF's competition here
BMYMP vs MAYNF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, MAYNF has a market cap of 138.8M. Regarding current trading prices, BMYMP is priced at $400.00, while MAYNF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas MAYNF's P/E ratio is -2.25. In terms of profitability, BMYMP's ROE is +0.39%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, BMYMP is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check MAYNF's competition here
BMYMP vs PTKFY Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, PTKFY has a market cap of 10.6M. Regarding current trading prices, BMYMP is priced at $400.00, while PTKFY trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas PTKFY's P/E ratio is 10.32. In terms of profitability, BMYMP's ROE is +0.39%, compared to PTKFY's ROE of +0.16%. Regarding short-term risk, BMYMP is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check PTKFY's competition here
BMYMP vs PSYGF Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, PSYGF has a market cap of 2M. Regarding current trading prices, BMYMP is priced at $400.00, while PSYGF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas PSYGF's P/E ratio is -0.17. In terms of profitability, BMYMP's ROE is +0.39%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, BMYMP is more volatile compared to PSYGF. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check PSYGF's competition here
BMYMP vs CRXTQ Comparison May 2026
BMYMP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMYMP stands at 814.6B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, BMYMP is priced at $400.00, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMYMP currently has a P/E ratio of 1777.78, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, BMYMP's ROE is +0.39%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, BMYMP is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for BMYMP.Check CRXTQ's competition here